Join Dr. Nick Zdenkowski for an insightful commentary on breast cancer therapeutics. He will cover the latest clinical trial results and emerging therapies, including CDK4/6 inhibitors, antibody-drug conjugates (ADCs), endocrine therapy, and PARP inhibitors. Dr. Zdenkowski will discuss the mechanisms of action, efficacy, and safety profiles of these treatments.
Videos